Improved design and screening of high bioactivity peptides for drug discovery
The discovery of peptides having high biological activity is very challenging mainly because there is an enormous diversity of compounds and only a minority have the desired properties. To lower cost and reduce the time to obtain promising compounds, machine learning approaches can greatly assist in the process and even replace expensive laboratory experiments by learning a predictor with existing data. Unfortunately, selecting ligands having the greatest predicted bioactivity requires a prohibitive amount of computational time. For this combinatorial problem, heuristics and stochastic optimization methods are not guaranteed to find adequate compounds. We propose an efficient algorithm based on De Bruijn graphs, guaranteed to find the peptides of maximal predicted bioactivity. We demonstrate how this algorithm can be part of an iterative combinatorial chemistry procedure to speed up the discovery and the validation of peptide leads. Moreover, the proposed approach does not require the use of known ligands for the target protein since it can leverage recent multi-target machine learning predictors where ligands for similar targets can serve as initial training data. Finally, we validated the proposed approach in vitro with the discovery of new cationic anti-microbial peptides. Source code is freely available at http://graal.ift.ulaval.ca/peptide-design/.